Announced Thu, 23 Jul · 20:35 IST
Q1 FY27 Investor Presentation: Revenue up 175% YoY
Mgmt Guided Margin PressurePromoter Disclosed Acquisition PlansAnalyst Day Multiyear TargetsOrder Pipeline DisclosedInvestor Communications View source PDF
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹41.85
prior close
₹43.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.5-5.5-5.9-8.2-3.2—————————
Up moveDown movePending
AI summary
Fineotex Chemical's Q1 FY27 revenue surged 175% YoY to Rs 376.63 Cr, driven by the CrudeChem Technologies acquisition (53.33% stake). PAT grew 93% to Rs 48.21 Cr. EBITDA margin fell 268 bps to 15.70%, and PAT margin dropped 543 bps to 12.80% due to acquisition mix. FY26 revenue rose 45% to Rs 772.23 Cr. US oilfield chemicals capacity doubled to 1,48,000 MTPA. ICRA rating upgraded to A+ positive.
Likely market impact
Strong revenue growth from CrudeChem acquisition drives scale, but margin compression is a concern. Debt-free balance sheet and capacity expansion support growth.